Zenotech Laboratories Limited (BOM:532039)
44.37
-1.34 (-2.93%)
At close: Jan 20, 2026
Zenotech Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | - | 267.02 | 196.86 | 111.42 | 24.15 | 24.58 | Upgrade |
Short-Term Investments | - | 0.02 | 0.02 | - | - | - | Upgrade |
Cash & Short-Term Investments | 317.37 | 267.04 | 196.88 | 111.42 | 24.15 | 24.58 | Upgrade |
Cash Growth | 44.76% | 35.64% | 76.69% | 361.42% | -1.75% | 127.14% | Upgrade |
Accounts Receivable | - | 74.54 | 32.49 | 33.24 | 39.28 | 38.03 | Upgrade |
Other Receivables | - | 11.05 | 15.33 | 6.76 | 1.58 | 1.51 | Upgrade |
Receivables | - | 85.6 | 47.82 | 39.99 | 40.86 | 39.54 | Upgrade |
Inventory | - | 0.91 | 8.6 | 0.24 | 1.35 | 0.86 | Upgrade |
Prepaid Expenses | - | 2.04 | 1.39 | 2.98 | 3.84 | 0.83 | Upgrade |
Other Current Assets | - | 4.3 | 6.94 | 8.01 | 3.56 | 7.66 | Upgrade |
Total Current Assets | - | 359.89 | 261.63 | 162.65 | 73.75 | 73.46 | Upgrade |
Property, Plant & Equipment | - | 644.41 | 675.38 | 703.64 | 711.88 | 764.14 | Upgrade |
Long-Term Deferred Tax Assets | - | 39.4 | 65.26 | 93.58 | 122.75 | - | Upgrade |
Other Long-Term Assets | - | 66.6 | 59.8 | 48.87 | 32.46 | 20.84 | Upgrade |
Total Assets | - | 1,110 | 1,062 | 1,009 | 940.84 | 858.44 | Upgrade |
Accounts Payable | - | 25.24 | 32.92 | 34.77 | 20.66 | 19.22 | Upgrade |
Accrued Expenses | - | 83.32 | 97.15 | 126.19 | 129.98 | 125.14 | Upgrade |
Current Income Taxes Payable | - | 12.15 | - | - | - | - | Upgrade |
Current Unearned Revenue | - | 5.11 | 5.11 | 5.11 | 5.11 | 5.11 | Upgrade |
Other Current Liabilities | - | 0.05 | 0.05 | - | - | - | Upgrade |
Total Current Liabilities | - | 125.87 | 135.23 | 166.07 | 155.76 | 149.47 | Upgrade |
Long-Term Debt | - | - | - | - | 60 | 206.56 | Upgrade |
Long-Term Unearned Revenue | - | 9.74 | 9.7 | 9.73 | 3.21 | 3.97 | Upgrade |
Pension & Post-Retirement Benefits | - | 7.09 | 6.16 | 5.26 | 4.52 | 4.28 | Upgrade |
Other Long-Term Liabilities | - | 6.3 | 5.55 | 4.97 | 10.95 | 10.07 | Upgrade |
Total Liabilities | - | 149 | 156.65 | 186.03 | 234.44 | 374.36 | Upgrade |
Common Stock | - | 610.31 | 610.31 | 610.31 | 610.31 | 610.31 | Upgrade |
Additional Paid-In Capital | - | 2,095 | 2,095 | 2,095 | 2,095 | 2,095 | Upgrade |
Retained Earnings | - | -1,744 | -1,800 | -1,883 | -1,999 | -2,222 | Upgrade |
Shareholders' Equity | 962.72 | 961.31 | 905.42 | 822.7 | 706.4 | 484.08 | Upgrade |
Total Liabilities & Equity | - | 1,110 | 1,062 | 1,009 | 940.84 | 858.44 | Upgrade |
Total Debt | - | - | - | - | 60 | 206.56 | Upgrade |
Net Cash (Debt) | 317.37 | 267.04 | 196.88 | 111.42 | -35.85 | -181.99 | Upgrade |
Net Cash Growth | 44.76% | 35.64% | 76.69% | - | - | - | Upgrade |
Net Cash Per Share | 5.19 | 4.38 | 3.23 | 1.83 | -0.59 | -2.98 | Upgrade |
Filing Date Shares Outstanding | 60.18 | 61.03 | 61.03 | 61.03 | 61.03 | 61.03 | Upgrade |
Total Common Shares Outstanding | 60.18 | 61.03 | 61.03 | 61.03 | 61.03 | 61.03 | Upgrade |
Working Capital | - | 234.02 | 126.4 | -3.42 | -82.01 | -76.01 | Upgrade |
Book Value Per Share | 16.11 | 15.75 | 14.84 | 13.48 | 11.57 | 7.93 | Upgrade |
Tangible Book Value | 962.72 | 961.31 | 905.42 | 822.7 | 706.4 | 484.08 | Upgrade |
Tangible Book Value Per Share | 16.11 | 15.75 | 14.84 | 13.48 | 11.57 | 7.93 | Upgrade |
Land | - | 10.83 | 10.83 | 10.83 | 10.83 | 10.83 | Upgrade |
Buildings | - | 212.53 | 211.96 | 211.96 | 211.96 | 210.15 | Upgrade |
Machinery | - | 939.58 | 917.68 | 844.97 | 828.49 | 793.79 | Upgrade |
Construction In Progress | - | 35.73 | 19.56 | 49.79 | 2.79 | 21.83 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.